132 related articles for article (PubMed ID: 33839977)
21. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.
Esajas MD; Duk JM; de Bruijn HW; Aalders JG; Willemse PH; Sluiter W; Pras B; ten Hoor K; Hollema H; van der Zee AG
J Clin Oncol; 2001 Oct; 19(19):3960-6. PubMed ID: 11579117
[TBL] [Abstract][Full Text] [Related]
22. Serum expression level of squamous cell carcinoma antigen, highly sensitive C-reactive protein, and CA-125 as potential biomarkers for recurrence of cervical cancer.
Guo S; Yang B; Liu H; Li Y; Li S; Ma L; Liu J; Guo W
J Cancer Res Ther; 2017; 13(4):689-692. PubMed ID: 28901315
[TBL] [Abstract][Full Text] [Related]
23. Predictive significance of CYFRA21-1, squamous cell carcinoma antigen and carcinoembryonic antigen for lymph node metastasis in patients with esophageal squamous cancer.
Mei X; Zhu X; Zuo L; Wu H; Guo M; Liu C
Int J Biol Markers; 2019 Jun; 34(2):200-204. PubMed ID: 31088185
[TBL] [Abstract][Full Text] [Related]
24. The curative role of radiotherapy in patients with isolated para-aortic node recurrence from cervical cancer and value of squamous cell carcinoma antigen for early detection.
Ogino I; Nakayama H; Kitamura T; Okamoto N; Inoue T
Int J Gynecol Cancer; 2005; 15(4):630-8. PubMed ID: 16014117
[TBL] [Abstract][Full Text] [Related]
25. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.
Duk JM; Groenier KH; de Bruijn HW; Hollema H; ten Hoor KA; van der Zee AG; Aalders JG
J Clin Oncol; 1996 Jan; 14(1):111-8. PubMed ID: 8558185
[TBL] [Abstract][Full Text] [Related]
26. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Gunji Y; Kobayashi S; Hayashi H; Ochiai T
Surgery; 2003 May; 133(5):486-94. PubMed ID: 12773976
[TBL] [Abstract][Full Text] [Related]
27. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.
Li X; Zhou J; Huang K; Tang F; Zhou H; Wang S; Jia Y; Sun H; Ma D; Li S
PLoS One; 2015; 10(4):e0122361. PubMed ID: 25860888
[TBL] [Abstract][Full Text] [Related]
28. Squamous cell carcinoma antigen, circulating immune complexes, and immunoglobulins in monitoring squamous cell carcinoma of head and neck: a study of the hellenic co-operative oncology group (HeCOG).
Makrantonakis P; Pectasides D; Aggouridakis C; Visvikis A; Daniilidis J; Fountzilas G
Am J Clin Oncol; 1999 Dec; 22(6):542-9. PubMed ID: 10597736
[TBL] [Abstract][Full Text] [Related]
29. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.
Ma Q; Liu W; Jia R; Jiang F; Duan H; Lin P; Zhang L; Long H; Zhao H; Ma G
World J Surg Oncol; 2016 May; 14():141. PubMed ID: 27151090
[TBL] [Abstract][Full Text] [Related]
30. Elevated levels of serum metalloproteinase 9 in patients with esophageal squamous cell carcinoma.
Łukaszewicz-Zajac M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
Pol Arch Med Wewn; 2009 Sep; 119(9):558-63. PubMed ID: 19776700
[TBL] [Abstract][Full Text] [Related]
31. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
[TBL] [Abstract][Full Text] [Related]
32. Serum concentrations of squamous-cell carcinoma antigen and tissue polypeptide antigen in the follow-up of patients with vulvar cancer.
Hefler L; Frischmuth K; Heinze G; Sliutz G; Leodolter S; Reinthaller A; Kainz C; Tempfer C
Int J Cancer; 1999 Oct; 83(2):167-70. PubMed ID: 10471522
[TBL] [Abstract][Full Text] [Related]
33. Use of serum squamous cell carcinoma antigen for follow-up monitoring of cervical cancer patients who were treated by concurrent chemoradiotherapy.
Yoon SM; Shin KH; Kim JY; Seo SS; Park SY; Moon SH; Cho KH
Radiat Oncol; 2010 Sep; 5():78. PubMed ID: 20840788
[TBL] [Abstract][Full Text] [Related]
34. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
Liu CZ; Zeng HX; Zhao JJ; Rong Y; Mo ZL; Li LA; Zhang JQ
Int J Gynecol Cancer; 2017 Jun; 27(5):994-1000. PubMed ID: 28498239
[TBL] [Abstract][Full Text] [Related]
35. The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy.
Ogino I; Nakayama H; Okamoto N; Kitamura T; Inoue T
Int J Gynecol Cancer; 2006; 16(3):1094-100. PubMed ID: 16803491
[TBL] [Abstract][Full Text] [Related]
36. Postreatment squamous cell carcinoma antigen as a survival prognostic factor in patients with locally advanced cervical cancer. A Spanish multicenter study. The SEGO Spain-GOG group.
Benito V; Lubrano A; Pérez-Regadera JF; Torné A; Gil-Moreno A; Tejerizo-Garcia Á; Vergés R; Díaz-Feijoo B;
Gynecol Oncol; 2021 Aug; 162(2):407-412. PubMed ID: 34119366
[TBL] [Abstract][Full Text] [Related]
37. Serum p53 antibody as a predictor of early recurrence in patients with postoperative esophageal squamous cell carcinoma.
Takahashi K; Miyashita M; Nomura T; Makino H; Futami R; Kashiwabara M; Katsuta M; Tajiri T
Dis Esophagus; 2007; 20(2):117-22. PubMed ID: 17439594
[TBL] [Abstract][Full Text] [Related]
38. Tumor marker index based on preoperative SCC and CYFRA 21-1 is a significant prognostic factor for patients with resectable esophageal squamous cell carcinoma.
Qiao Y; Chen C; Yue J; Yu Z
Cancer Biomark; 2019; 25(3):243-250. PubMed ID: 31282406
[TBL] [Abstract][Full Text] [Related]
39. [Clinical significance of serum squamous cell carcinoma antigen in the diagnosis, treatment and prognosis of cervical squamous cell carcinoma].
Luan XM; Zhang Y; Wang SZ; Wang N; Li W; Zhang Q; Wei H; Zhang SL
Zhonghua Yi Xue Za Zhi; 2012 May; 92(19):1330-3. PubMed ID: 22883121
[TBL] [Abstract][Full Text] [Related]
40. Association of pretreatment SUV
Shou H; Yasuo Y; Yuan S; Lou H; Ni J
Int J Gynaecol Obstet; 2021 Jan; 152(1):112-117. PubMed ID: 33141954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]